Cite
Häppölä P, Gormley P, Nuottamo ME, et al. Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families. Cephalalgia. 2021;3331024211045651doi: 10.1177/03331024211045651.
Häppölä, P., Gormley, P., Nuottamo, M. E., Artto, V., Sumelahti, M. L., Nissilä, M., Keski-Säntti, P., Ilmavirta, M., Kaunisto, M. A., Hämäläinen, E. I., Ripatti, S., Pirinen, M., Wessman, M., Palotie, A., Kallela, M. (2021). Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families. Cephalalgia : an international journal of headache, 3331024211045651. https://doi.org/10.1177/03331024211045651
Häppölä, Paavo, et al. "Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families." Cephalalgia : an international journal of headache vol. (2021): 3331024211045651. doi: https://doi.org/10.1177/03331024211045651
Häppölä P, Gormley P, Nuottamo ME, Artto V, Sumelahti ML, Nissilä M, Keski-Säntti P, Ilmavirta M, Kaunisto MA, Hämäläinen EI, Ripatti S, Pirinen M, Wessman M, Palotie A, Kallela M. Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families. Cephalalgia. 2021 Oct 14;3331024211045651. doi: 10.1177/03331024211045651. Epub 2021 Oct 14. PMID: 34648375.
Copy
Download .nbib